Earnings Feed
Start Free
$REGN·4

REGENERON PHARMACEUTICALS INC · Sep 20, 4:24 PM ET

REGENERON PHARMACEUTICALS INC 4

4 · REGENERON PHARMACEUTICALS INC · Filed Sep 20, 2013

Insider Transaction Report

Form 4
Period: 2013-09-18
REGENERON PHARMACEUTICALS INCREGN
ROBERTS WILLIAM
VP Regul Devel & Clin Safety
Transactions
  • Sale

    Common Stock

    2013-09-18$304.00/sh−15,000$4,560,000→ 20,644 total
  • Gift

    Common Stock

    2013-09-19−4,000→ 16,644 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2013-09-18−15,000→ 9,048 total
    Exercise: $16.80Exp: 2018-12-17→ Common Stock (15,000 underlying)
  • Gift

    Common Stock

    2013-06-13+4,000→ 20,644 total
  • Exercise/Conversion

    Common Stock

    2013-09-18$16.80/sh+15,000$252,000→ 35,644 total
  • Gift

    Common Stock

    2013-06-13−4,000→ 13,447 total(indirect: By Spouse)
Holdings

  • Common Stock

    (indirect: by GRAT)
    17,000

  • Common Stock

    (indirect: By Trust)
    1,200

  • Common Stock

    (indirect: By 401(k))
    4,388

  • Common Stock

    (indirect: By Trust)
    1,200
Footnotes (3)
  • [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  • [F2]Gift of Common Stock to a charitable foundation.
  • [F3]The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT